JBC
ASPN icon

Jefferson Bridge Capital’s Aspen Aerogels ASPN Stock Holding History

Jefferson Bridge Capital’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,450
Closed -$32.4K – 54
2025
Q4 		$32.4K Buy
+11,450
New +$59K 0.03% 54

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Jefferson Bridge Capital's ASPN Position: Q1 2026 in Review

Jefferson Bridge Capital sold out of Aspen Aerogels (ASPN) in Q1 2026, closing a stake of 11,450 shares — an estimated $32.4K sold.

Jefferson Bridge Capital first reported a position in ASPN in Q4 2025 and held it in 1 quarter. The position peaked at $32.4K in Q4 2025. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Jefferson Bridge Capital reported no remaining Aspen Aerogels position as of Q1 2026 after selling out during the quarter.
  • Jefferson Bridge Capital sold 11,450 Aspen Aerogels shares in Q1 2026, an estimated $32.4K.
  • Jefferson Bridge Capital first reported a position in Aspen Aerogels in Q4 2025 and held it in 1 quarter.
  • Jefferson Bridge Capital's Aspen Aerogels position peaked at $32.4K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Jefferson Bridge Capital's 13F filing for Q1 2026, filed 7 May 2026.